Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-005266
Filing Date
2018-05-01
Accepted
2018-05-01 11:24:00
Documents
1
Period of Report
2018-04-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4040418amouyal_wizepharma.html 4  
1 OWNERSHIP DOCUMENT f4040418amouyal_wizepharma.xml 4 4050
  Complete submission text file 0001213900-18-005266.txt   5538
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 MAZEH ST. TEL AVIV L3 65213
Business Address
Franck Amouyal (Reporting) CIK: 0001723469 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 18793974